vs
デッカーズブランズ(DECK)とIdexx Laboratories(IDXX)の財務データ比較。上の社名をクリックして会社を切り替えられます
デッカーズブランズの直近四半期売上が大きい($2.0B vs $1.1B、Idexx Laboratoriesの約1.8倍)。デッカーズブランズの純利益率が高く(24.6% vs 22.8%、差は1.8%)。Idexx Laboratoriesの前年同期比売上増加率が高い(14.3% vs 7.1%)。デッカーズブランズの直近四半期フリーキャッシュフローが多い($1.0B vs $326.3M)。過去8四半期でデッカーズブランズの売上複合成長率が高い(42.8% vs 6.4%)
デッカーズアウトドアコーポレーション(事業名デッカーズブランズ)は1973年創業の米国の靴設計・流通企業で、本社はカリフォルニア州ゴレタにあります。創業者はダグ・オットーとカール・F・ロプカーで、傘下にUGG、Teva、Hokaなどの人気ブランドを擁しています。
IDEXXラボラトリーズは1983年設立の米国多国籍企業で、伴侶動物獣医療、家畜・家禽、水質検査、乳製品分野向けの製品・サービスの開発・製造・流通を手がけています。本社はメイン州ウェストブルックにあり、EMEA地域の拠点はオランダのホーフドルプに置かれています。
DECK vs IDXX — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $2.0B | $1.1B |
| 純利益 | $481.1M | $248.2M |
| 粗利率 | 59.8% | 60.3% |
| 営業利益率 | 31.4% | 28.9% |
| 純利益率 | 24.6% | 22.8% |
| 売上前年比 | 7.1% | 14.3% |
| 純利益前年比 | 5.3% | 14.8% |
| EPS(希薄化後) | $3.33 | $3.09 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $964.5M | $1.1B | ||
| Q1 25 | $1.0B | $998.4M | ||
| Q4 24 | $1.8B | $954.3M | ||
| Q3 24 | $1.3B | $975.5M | ||
| Q2 24 | $825.3M | $1.0B | ||
| Q1 24 | $959.8M | $964.1M |
| Q4 25 | $481.1M | $248.2M | ||
| Q3 25 | $268.2M | $274.6M | ||
| Q2 25 | $139.2M | $294.0M | ||
| Q1 25 | $151.4M | $242.7M | ||
| Q4 24 | $456.7M | $216.1M | ||
| Q3 24 | $242.3M | $232.8M | ||
| Q2 24 | $115.6M | $203.3M | ||
| Q1 24 | $127.5M | $235.6M |
| Q4 25 | 59.8% | 60.3% | ||
| Q3 25 | 56.2% | 61.8% | ||
| Q2 25 | 55.8% | 62.6% | ||
| Q1 25 | 56.7% | 62.4% | ||
| Q4 24 | 60.3% | 59.8% | ||
| Q3 24 | 55.9% | 61.1% | ||
| Q2 24 | 56.9% | 61.7% | ||
| Q1 24 | 56.2% | 61.5% |
| Q4 25 | 31.4% | 28.9% | ||
| Q3 25 | 22.8% | 32.1% | ||
| Q2 25 | 17.1% | 33.6% | ||
| Q1 25 | 17.0% | 31.7% | ||
| Q4 24 | 31.0% | 27.4% | ||
| Q3 24 | 23.3% | 31.2% | ||
| Q2 24 | 16.1% | 26.3% | ||
| Q1 24 | 15.0% | 31.0% |
| Q4 25 | 24.6% | 22.8% | ||
| Q3 25 | 18.7% | 24.8% | ||
| Q2 25 | 14.4% | 26.5% | ||
| Q1 25 | 14.8% | 24.3% | ||
| Q4 24 | 25.0% | 22.7% | ||
| Q3 24 | 18.5% | 23.9% | ||
| Q2 24 | 14.0% | 20.3% | ||
| Q1 24 | 13.3% | 24.4% |
| Q4 25 | $3.33 | $3.09 | ||
| Q3 25 | $1.82 | $3.40 | ||
| Q2 25 | $0.93 | $3.63 | ||
| Q1 25 | $-2.78 | $2.96 | ||
| Q4 24 | $3.00 | $2.62 | ||
| Q3 24 | $1.59 | $2.80 | ||
| Q2 24 | $4.52 | $2.44 | ||
| Q1 24 | $4.82 | $2.81 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $2.1B | $180.1M |
| 総負債低いほど良い | — | $450.0M |
| 株主資本純資産 | $2.6B | $1.6B |
| 総資産 | $4.1B | $3.4B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.28× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $2.1B | $180.1M | ||
| Q3 25 | $1.4B | $208.2M | ||
| Q2 25 | $1.7B | $164.6M | ||
| Q1 25 | $1.9B | $164.0M | ||
| Q4 24 | $2.2B | $288.3M | ||
| Q3 24 | $1.2B | $308.6M | ||
| Q2 24 | $1.4B | $401.6M | ||
| Q1 24 | $1.5B | $397.4M |
| Q4 25 | — | $450.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $617.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.6B | $1.6B | ||
| Q3 25 | $2.5B | $1.6B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $2.5B | $1.4B | ||
| Q4 24 | $2.6B | $1.6B | ||
| Q3 24 | $2.2B | $1.6B | ||
| Q2 24 | $2.1B | $1.6B | ||
| Q1 24 | $2.1B | $1.6B |
| Q4 25 | $4.1B | $3.4B | ||
| Q3 25 | $3.8B | $3.4B | ||
| Q2 25 | $3.8B | $3.3B | ||
| Q1 25 | $3.6B | $3.2B | ||
| Q4 24 | $4.0B | $3.3B | ||
| Q3 24 | $3.4B | $3.4B | ||
| Q2 24 | $3.3B | $3.4B | ||
| Q1 24 | $3.1B | $3.4B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $1.0B | $355.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $1.0B | $326.3M |
| FCFマージンFCF / 売上 | 52.1% | 29.9% |
| 設備投資強度設備投資 / 売上 | 1.1% | 2.7% |
| キャッシュ転換率営業CF / 純利益 | 2.17× | 1.43× |
| 直近12ヶ月FCF直近4四半期 | $929.1M | $1.1B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.0B | $355.8M | ||
| Q3 25 | $8.1M | $402.3M | ||
| Q2 25 | $36.1M | $185.7M | ||
| Q1 25 | $-73.0M | $238.0M | ||
| Q4 24 | $1.1B | $262.0M | ||
| Q3 24 | $-90.5M | $220.1M | ||
| Q2 24 | $112.7M | $248.3M | ||
| Q1 24 | $-28.7M | $198.6M |
| Q4 25 | $1.0B | $326.3M | ||
| Q3 25 | $-13.9M | $371.2M | ||
| Q2 25 | $12.2M | $151.6M | ||
| Q1 25 | $-89.4M | $207.9M | ||
| Q4 24 | $1.1B | $232.8M | ||
| Q3 24 | $-113.4M | $192.0M | ||
| Q2 24 | $90.1M | $215.0M | ||
| Q1 24 | $-44.0M | $168.3M |
| Q4 25 | 52.1% | 29.9% | ||
| Q3 25 | -1.0% | 33.6% | ||
| Q2 25 | 1.3% | 13.7% | ||
| Q1 25 | -8.8% | 20.8% | ||
| Q4 24 | 58.6% | 24.4% | ||
| Q3 24 | -8.6% | 19.7% | ||
| Q2 24 | 10.9% | 21.4% | ||
| Q1 24 | -4.6% | 17.5% |
| Q4 25 | 1.1% | 2.7% | ||
| Q3 25 | 1.5% | 2.8% | ||
| Q2 25 | 2.5% | 3.1% | ||
| Q1 25 | 1.6% | 3.0% | ||
| Q4 24 | 1.3% | 3.1% | ||
| Q3 24 | 1.7% | 2.9% | ||
| Q2 24 | 2.7% | 3.3% | ||
| Q1 24 | 1.6% | 3.1% |
| Q4 25 | 2.17× | 1.43× | ||
| Q3 25 | 0.03× | 1.47× | ||
| Q2 25 | 0.26× | 0.63× | ||
| Q1 25 | -0.48× | 0.98× | ||
| Q4 24 | 2.40× | 1.21× | ||
| Q3 24 | -0.37× | 0.95× | ||
| Q2 24 | 0.97× | 1.22× | ||
| Q1 24 | -0.22× | 0.84× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
DECK
| UGG Brand Segment | $1.3B | 67% |
| Hoka Brand Segment | $628.9M | 32% |
| Other Brands Segment | $23.2M | 1% |
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |